- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SUPN
Recent news which mentions SUPN
Earnings Scheduled For November 8, 2023
November 08, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Monday
October 02, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
September 15, 2023
From Benzinga
Tickers
SUPN
From Motley Fool
Earnings Scheduled For May 9, 2023
May 09, 2023
From Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
From Benzinga
FDA Rejects Supernus Pharma's Minimally Invasive Parkinson's Therapy
October 10, 2022
Tickers
SUPN
From Benzinga
From Benzinga
2 Small-Cap Stocks With Large-Cap Potential
July 11, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
This simple strategy of picking cheap stocks has been a repeat winner. Here are a few dozen names to get you started.
December 28, 2021
From MarketWatch
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
Supernus Pharmaceuticals, inc (SUPN) Q3 2021 Earnings Call Transcript
November 04, 2021
Tickers
SUPN
From Motley Fool
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
Earnings Scheduled For November 3, 2021
November 03, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
Why Supernus' Acquisition of Adamas Is a Smart Move
October 21, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.